Commercially antibodies were used: Vinculin (Sigma, SAB4200080, 1:8000), IκBα (Cell Signaling, #9242, 1:1000), P65 (Cell Signaling, #8242, 1:1000), FLAG (abcam, ab1162), 1:1000), Myc (Cell Signaling, #2276, 1:1000), MITOFUSIN1 (Cell Signaling, #14739, 1:1000), OPA1 (Cell Signaling, #67589, 1:1000), Total OXPHOS Rodent WB Antibody Cocktail antibodies (Abcam, ab110413, 1:1000), peroxidase-conjugated secondary mouse (Cell Signaling, #7076, 1:2000) and peroxidase-conjugated secondary Rabbit (Cell Signaling, #7074, 1:2000). TNFα (300-01A and 315-01A) was purchased from Peprotech. Cisplatin (S1166) was purchased from Selleckchem. ZINC639309 (MolPort-002-836-946) was purchased from MolPort and Psammaplin-A (SC-258049) was purchased from Santa Cruz. NAC (N-acetylcysteine) was purchased from Sigma Aldrich.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.